comparemela.com
  1. Home
  2. Live Updates
  3. Simcere Pharmaceutical Group Ltd - Breaking News

Latest Breaking News On - Simcere pharmaceutical group ltd - Page 4 : comparemela.com

DGAP-News: Vivoryon Therapeutics N V : Vivoryon Therapeutics N V Reports Full Year 2021 Financial Results and Highlights Operational Progress

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Annual Results/Annual Report Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.

Hong kongUnited kingdomMacau generalValeria fisherFlorian schmidUlrich dauerManuela baderMichael schaefferInternational financial reporting standardsDrug administrationTrophic communicationsSimcere pharmaceutical group ltdInternational journal of molecular sciences hoffmannAlzheimer disease cooperative studyCorporate developmentJournal alzheimer research therapy vijverberg

DGAP-News: Vivoryon Therapeutics N V : Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with Alzheimer s Disease Seite 1

28.02.2022 - DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous Vivoryon Therapeutics N.V.: Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with . Seite 1

Renhong tangMichael schaefferNational medical products administrationSimcere pharmaceutical group ltdChina centerEuronext amsterdamDrug evaluationClinical trial applicationGreater chinaExecutive vice presidentBusiness officerVivoryon therapeuticsGap news

Vivoryon Therapeutics N V : Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clini

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous28.02.2022 / 01:00 The issuer is solely responsible for the content of this announcement.Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with Alzheimer's Dis.

Renhong tangJason baoSophia hergenhanManuela baderJian houMichael schaefferSimcere pharmaceutical groupNational medical products administrationDrug administrationTrophic communicationsSimcere pharmaceutical group ltdChina centerDistribution servicesSimcere announceChinese clinical trial applicationEuronext amsterdam

DGAP-News: Vivoryon Therapeutics N V : Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with Alzheimer s Disease

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous Vivoryon Therapeutics N.V.: Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application

Noord hollandRenhong tangJason baoHalle saaleSophia hergenhanManuela baderJian houMichael schaefferSimcere pharmaceutical groupDrug administrationTrophic communicationsSimcere pharmaceutical group ltdDistribution servicesNational medical products administrationNews serviceChina center

Kazia Therapeutics : Annual Report (SEC Filing - 20-F)

Form 20-F Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION . | October 7, 2021

New yorkUnited statesMemorial sloan kettering cancer centerHong kongDistrict of columbiaUnited kingdomKate hillWestern australiaSoult ukpyolsiSouth koreaNew zealandNew south walesDana farber cancer instituteSouth walesCommonwealth of australiaJose pablo leone

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.